MET and cancer: Tumour RK36 had acquired a somatic MET mutation, c.G799A (p.Glu267Lys; Table 2) that has strong predicted functional effects and lies next to a residue recurrently mutated in human cancer, but has not itself been reported as mutated (http://cancer.sanger.ac.uk/cosmic/gene/overview?ln=MET).